MS

Electron activated dissociation (EAD) and the Zeno trap provide high sensitivity and certainty in mass spectrometry results. 

A study of 16,000 people suggests that human herpesvirus 6A is a risk factor for developing multiple sclerosis, reinvigorating a neglected hypothesis that the virus could be involved in triggering the disease.

Many dominant T cell variants decline during pregnancy and reappear afterward, possibly explaining why relapses of the autoimmune disease are less common when women are expecting.

A Chicago-based center that has long operated a clinical trial program for stem cell therapies, has stopped recruiting further patients as its chief, Richard Burt, leaves for a research sabbatical.

Molecules produced by resident bacteria and their hosts may signal immune cells to attack the body’s own tissues.

On embracing technology and collaboration to tackle brain disorders like multiple sclerosis

A list of this year’s newsworthy successes—and failures—in drug development